Cart is empty Researchers from Kumamoto University have identified a liver-derived protein, serine protease inhibitor A1 (SerpinA1), as a key regulator in combating obesity and enhancing glucose metabolism. This study, published in Nature Communications, sheds light on how activating brown adipose tissue (BAT) could pave the way for innovative treatments for diabetes and metabolic disorders.
Leave A Comment